Measuring medication adherence

Population Health Management

Volumn 12, Issue 1, 2009, Pages 25-30

  Cooper, Jason ^a   Hall, Lakevia ^a   Penland, Angel ^a   Krueger, Andrew ^a   May, Jeanette ^b  

^a CVS Caremark   (United States)

^b DMAA: the Care Continuum Alliance   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; BILE ACID SEQUESTRANT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SULFONYLUREA;

ADULT; AGED; ARTICLE; CALCULATION; CONGESTIVE HEART FAILURE; CONSENSUS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEASIBILITY STUDY; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; HYPERTENSION; MALE; MEDICATION THERAPY MANAGEMENT; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; VALIDITY; INSURANCE; MIDDLE AGED; REPRODUCIBILITY; UNITED STATES;

AGED; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 65349092040     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2008.0031     Document Type: Article

References (6)

1. Cramer JA, Roy A, Burell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008; 2:44-47.
2. Howell N, Trotter R, Mottram DR, Rowe PH. Compliance with statins in primary care. Pharm J. 2004;272:1-40.
3. Lawrence DB, Allison W, Chen JC, Demand M. Improving medication adherence with a targeted, technology-driven disease management intervention. Dis Manag. 2008;11:141-144.
4. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794-811.
5. Zyczynski TM, Coyne KS. Hypertension and current issues in compliance and patient outcomes. Curr Hypertens Rep. 2000;2:510-514.
6. Urquhart J. Defining the margins for errors in patient compliance with prescribed drug regimens. Pharmacoepidemiol Drug. 2000;9:565-568.